Skip to content

Break Down Clinical Study Cohort Size, Endpoints, and Confounders

Read past press-release headlines on medical studies by isolating primary vs. surrogate endpoints, absolute vs. relative risk reduction, dropout rates, and exclusion criteria.

Copy the prompt and paste it into the AI assistant you already use.

Clinical paper breakdowns are strictly educational to help readers understand published research and prepare questions for licensed physicians; they never constitute medical advice, diagnosis, or treatment guidance.

Four statistical reality checks inside every clinical research paper

  1. 01

    Always convert Relative Risk into Absolute Risk

    Cutting event risk from 2.0% to 1.3% is touted as a '35% risk reduction' in headlines, yet represents a 0.7 percentage-point absolute shift.

  2. 02

    Check Table 1 baseline demographics and exclusions

    See whether older adults, pregnant patients, or common comorbidities were excluded from enrollment before generalizing findings.

  3. 03

    Distinguish clinical outcomes from surrogate markers

    Shrinking a lab biomarker or scan shadow does not always translate into improved survival or quality-of-life outcomes.

  4. 04

    Inspect attrition and adverse-event discontinuations

    Check the CONSORT flow diagram to see how many treatment-arm participants dropped out early due to side effects.

How it works in practice

Journal Paper Results & Methods Excerpt

Among 1,840 randomized adults aged 40–68 without baseline renal impairment (eGFR <60 excluded), the composite primary endpoint occurred in 2.4% (22/920) of the active group versus 3.8% (35/920) of placebo over 24 months (HR 0.63; 95% CI, 0.37–1.07; p=0.088). In a non-prespecified exploratory subgroup of patients <55, nominal reduction reached 52%. Discontinuation due to GI adverse events was 14.1% vs. 3.2%.

Plain-English Study Audit

• Headline Reality: Primary trial MISSED statistical significance (p=0.088; CI crosses 1.0). • Absolute Difference: Events were 2.4% vs. 3.8% (1.4% absolute difference over 2 yrs)—and non-significant. • Caveats: '52% cut in <55s' was an unplanned post-hoc slice; adults >68 or with kidney disease were excluded; 14.1% quit over GI side effects.

Surfaces missed primary p-values and dropout rates often glossed over in media summaries.

Common questions

Why do health news articles often exaggerate clinical study results?

Press releases highlight relative percentages or exploratory subgroup slices while omitting small absolute differences, wide confidence intervals, or narrow patient cohorts.

What does 'surrogate endpoint' mean when reading a medical trial?

A lab value or imaging measurement used as a stand-in for real patient outcomes like hospital admission, symptom relief, or overall survival.

How can patients or caregivers use a trial breakdown responsibly?

Bring a concise list of cohort criteria and outcome questions to your treating specialist to ask whether a study meaningfully applies to your specific clinical picture.

Learn more

Related guides and background articles for this task